Document Details
Form
Filing Date
Apr 08, 2024
Document Date
Mar 14, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
BioXcel Therapeutics
Issuer
BioXcel Therapeutics, Inc.